These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11284211)

  • 1. Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue.
    Howorka K; Pumprla J; Schlusche C; Wagner-Nosiska D; Schabmann A; Bradley C
    Qual Life Res; 2000; 9(8):915-30. PubMed ID: 11284211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ.
    Bradley C; Plowright R; Stewart J; Valentine J; Witthaus E
    Health Qual Life Outcomes; 2007 Oct; 5():57. PubMed ID: 17927832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties and responsiveness of the Turkish version of the Diabetes Treatment Satisfaction Questionnaire (s) on a sample of diabetics of three consecutive monitoring periods.
    Özmen B; Eser E; Özkaya Kafesçiler S; Pala T; Güçlü F; Hekimsoy Z
    Acta Diabetol; 2010 Dec; 47 Suppl 1():123-31. PubMed ID: 19936604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.
    Kotsanos JG; Vignati L; Huster W; Andrejasich C; Boggs MB; Jacobson AM; Marrero D; Mathias SD; Patrick D; Zalani S; Anderson J
    Diabetes Care; 1997 Jun; 20(6):948-58. PubMed ID: 9167105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire.
    Sampson MJ; Singh H; Dhatariya KK; Jones C; Walden E; Bradley C
    Diabet Med; 2009 Jul; 26(7):729-35. PubMed ID: 19573123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire.
    Kontodimopoulos N; Arvanitaki E; Aletras VH; Niakas D
    Health Qual Life Outcomes; 2012 Feb; 10():17. PubMed ID: 22296783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perceptions of diabetes and diabetes therapy: assessing quality of life.
    Bradley C; Speight J
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S64-9. PubMed ID: 12324988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin lispro, a new insulin analog.
    Kucera ML; Graham JP
    Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ).
    Nicolucci A; Giorgino R; Cucinotta D; Zoppini G; Muggeo M; Squatrito S; Corsi A; Lostia S; Pappalardo L; Benaduce E; Girelli A; Galeone F; Maldonato A; Perriello G; Pata P; Marra G; Coronel GA
    Diabetes Nutr Metab; 2004 Aug; 17(4):235-43. PubMed ID: 15575345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from premixed human insulin to premixed insulin lispro: a prospective study comparing the effects on glucose control and quality of life.
    Yamada S; Watanabe M; Kitaoka A; Shiono K; Atsuda K; Tsukamoto Y; Kawana Y; Irie J
    Intern Med; 2007; 46(18):1513-7. PubMed ID: 17878636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
    Peyrot M; Rubin RR; Polonsky WH; Best JH
    Curr Med Res Opin; 2010 May; 26(5):1047-54. PubMed ID: 20199136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries.
    Boels AM; Vos RC; Hermans TGT; Zuithoff NPA; Müller N; Khunti K; Rutten GEHM;
    BMJ Open; 2017 Jul; 7(7):e016180. PubMed ID: 28701411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin aspart(NN-X14)].
    Namba M
    Nihon Rinsho; 2001 Nov; 59(11):2144-50. PubMed ID: 11712399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.